Loading data for PRVA — first visit, this takes a few seconds.

Preisalarm

Privia Health Group Inc. (PRVA)

NasdaqGS: PRVA · Echtzeitkurs · USD

21.52

+0.02 (0.09%)

Zum Schluss: Aug 18, 2026, 8:00 PM

0.09% (1D)

Keine Daten verfügbar

Geld	15.64
Marktkapitalisierung	2.75 Mrd
Umsatz (TTM)	2.36 Mrd
Nettogewinn (TTM)	28.12 Mio
Beta	0.90
EPS (ttm)	0.22
KGV (TTM)	97.82
Forward-KGV	20.24
KBV (TTM)	3.47
KUV (TTM)	1.17
Earnings Date	Nov 5, 2026

Brief	27.44
Volumen	914,368
Ø Vol. (20D)	1,182,300
Eröffnung	21.56
Vortagesschluss	21.50
Tagesspanne	21.43 - 21.85
52-Wk Range	19.53 - 28.82
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über PRVA

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power...

[Mehr lesen]

Branche Health Information Services

Sektor Healthcare

IPO Datum Apr 28, 2021

Mitarbeiter 1,226

Börse NasdaqGS

Tickersymbol PRVA

Website https://www.priviahealth.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Privia Health 2.12 Mrd, ein Anstieg von 22.26% im Vergleich zum Vorjahr (1.74 Mrd). Der Gewinn lag bei 22.92 Mio, ein Anstieg von 59.33 %.

Finanzberichte

Gewinnüberraschung

Privia Health hat die Quartalszahlen am Aug 6, 2026 veröffentlicht:

Umsatz von $632.63 Mio verfehlt die Erwartungen um $0, mit 21.39% Wachstum im Jahresvergleich.

EPS von 0.19 verfehlt die Erwartungen um -0.05, mit -20.83% Rückgang im Jahresvergleich.

Nächste Ergebnisveröffentlichung

Privia Health Group Inc. wird voraussichtlich die Quartalszahlen veröffentlichen am Nov 5, 2026, vor Börseneröffnung.
Analysten erwarten einen Umsatz von ... Upgrade

Nachrichten

vor 4 Tagen · StockStory

The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call

Privia Health’s second quarter results were met with a negative market reaction as investors digested the company’s strong revenue growth alongside a material shortfall in non-GAAP profit relative to ...

vor 6 Tagen · Insider Monkey

Privia Health’s (PRVA) Guidance Keeps Rising, So Is The Stock Keeping Pace?

Privia Health (NASDAQ:PRVA) just turned in a quarter that checked every box management set for itself, and then raised the bar again for the rest of the year. On the company’s August 6 earnings call, ...

vor 6 Tagen · Motley Fool

Privia Health (PRVA) Q2 2026 Earnings Call Transcript

Net income surged 237% while attributed lives grew 19%, signaling strong operational momentum.

vor 1 Woche · StockStory

PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus

Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 million. Its non-GAAP profit of $0.19 per sha...

vor 1 Woche · Simply Wall St.

Privia Health Group (PRVA) Is Down 5.2% After Raising 2026 Revenue Guidance And Expanding Footprint

In the past week, Privia Health Group, Inc. reported second-quarter 2026 results showing sales of US$632.63 million and net income of US$9.05 million, both higher than a year earlier, and modestly hig...

Seite 1 von 2

Privia Health Group Inc. (PRVA)